Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis

Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis

Background & Aims Non-selective β blockers (NSBBs) may negatively influence renal function through decreasing heart rate and cardiac output. This study aimed to systematically investigate their association.Methods PubMed, EMBASE, and Cochrane library databases were searched to identify all relev...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiangbo Xu, Fangbo Gao, Ting Wang, Zuyao Yang, Qingchun Zhao, Xingshun Qi
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Annals of Medicine
Subjects:	Nonselective β blockers propranolol acute kidney injury hepatorenal syndrome liver cirrhosis
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2024.2305935
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Disorders of the central nervous system cognitive and mnestic functions in genetic arterial hypertension and with the use of beta-blockers of different generations
by: A. O. Svitlytskyi, et al.
Published: (2024-09-01)

Principles of portal hypertension treatment at patients with liver cirrhosis
by: Ye. A. Fedosina, et al.
Published: (2012-09-01)

Clinical Recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on Diagnosis and Treatment of Liver Fibrosis, Cirrhosis and Their Complications
by: V. T. Ivashkin, et al.
Published: (2022-03-01)

The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients
by: Mohamed Adel Abd Elaziz, et al.
Published: (2024-12-01)

Treatment of infantile hemangioma with topical β-blockers in pediatric practice: a review of the literature
by: O.V. Bogomolets, et al.
Published: (2023-12-01)

β-receptor blocker enhances anti-tumor immunity via inhibiting lactate-induced norepinephrine metabolism of macrophages during malignant pleural effusion
by: Ru Zhang, et al.
Published: (2025-01-01)

Hepatorenal syndrome in decompensated portal hypertension
by: M.I. Tutchenko, et al.
Published: (2024-12-01)

Effect of β-blocker on clinical outcomes in patients with traumatic brain injury: a retrospective propensity-matched study
by: Yaxin Zhang, et al.
Published: (2025-01-01)

Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
by: Yu. V. Khoronko, et al.
Published: (2021-04-01)

Impact of acute respiratory distress syndrome on outcome in critically ill patients with liver cirrhosis
by: Pischtaz Adel Tariparast, et al.
Published: (2025-02-01)

Development and validation of a machine learning-based prediction model for hepatorenal syndrome in liver cirrhosis patients using MIMIC-IV and eICU databases
by: Fengwei Yao, et al.
Published: (2025-01-01)

Comparison of Medical Treatments According to the Characteristics of Idiopathic Premature Ventricular Contractions: Beta-blockers or Calcium Channel Blockers?
by: Omer Faruk BAYCAN, et al.
Published: (2023-03-01)

Acute kidney injury is associated with liver-related outcomes in patients with hepatitis B virus infection: a retrospective cohort study
by: Jiao Liu, et al.
Published: (2025-01-01)

Systemic reviews and meta-analysis of the use of midodrine in hepatorenal syndrome
by: Prem Balaji Reddy Lankapothu, et al.
Published: (2024-09-01)

Opioid sparing anesthesia in patients with liver cirrhosis undergoing liver resection: a controlled randomized double-blind study
by: Eman Sayed Ibrahim, et al.
Published: (2025-02-01)

Hypercoagulation syndrome at liver cirrhosis
by: I. A. Kurkina, et al.
Published: (2014-12-01)

Effects of 24-hour urine-output trajectories on the risk of acute kidney injury in critically ill patients with cirrhosis: a retrospective cohort analysis
by: Jia Wang, et al.
Published: (2024-12-01)

Investigation of hemostasis by thromboelastography in the patient with liver cirrhosis (Clinical case)
by: Ye. L. Bulanova, et al.
Published: (2011-12-01)

Rationale and Design of a Randomized, Open‐Label, Parallel‐Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT‐HT)
by: Kazuomi Kario, et al.
Published: (2025-01-01)

Efficacy of Contezolid in the Treatment of Catheter-Related Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus in a Patient with Hepatorenal Syndrome and Acute Kidney Injury: A Case Report
by: Zhang X, et al.
Published: (2025-01-01)

Consistency analysis of two US techniques for evaluating hepatic steatosis in patients with metabolic dysfunction-associated steatotic liver disease
by: Fei Chen, et al.
Published: (2025-01-01)

Generalized tuberculosis with long-term course in the guise of liver cirrhosis
by: Z. A. Lemeshko, et al.
Published: (2015-07-01)

Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis
by: Yoshihiro Inoue, et al.
Published: (2020-09-01)

Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
by: Jung Hee Kim, et al.
Published: (2025-12-01)

Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B
by: I. G. Bakulin
Published: (2009-02-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Forgettable in the care of liver cirrhosis: the unseen culprits of progression from bad to worse
by: Maha Elsabaawy, et al.
Published: (2024-03-01)

Cytokines in Liver Cirrhosis (Their Importance in Assessing Activity and Decompensation)
by: G. K. Mirodzhov, et al.
Published: (2023-11-01)

A new prognostic model based on serum apolipoprotein AI in patients with HBV-ACLF and acutely decompensated liver cirrhosis
by: Ruidong Mo, et al.
Published: (2025-02-01)

Effects of B-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
by: Al-kuraishy, Hayder M., et al.
Published: (2023)

Evaluation of the effects of the pandemic period on cirrhosis patients
by: Rezan Karaali, et al.
Published: (2023-09-01)

Infection with hepatitis C virus as a cause of cirrhosis – case study
by: Lidia Sierpińska, et al.
Published: (2025-01-01)

Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01)

Benefits of Liver Volume and Serum Zinc Level Assessment for the Screening of Covert Hepatic Encephalopathy in Patients with Child–Pugh Class A Cirrhosis
by: Masanori Fukushima, et al.
Published: (2024-12-01)

Efficacy and safety of propranolol tablets vs. oral solution in neonates with severe infantile hemangiomas: a retrospective study in China
by: Zhiping Wu, et al.
Published: (2025-01-01)

Microextraction-Based Techniques for the Determination of Beta-Blockers in Biological Fluids: A Review
by: Styliani Nisyriou, et al.
Published: (2025-01-01)

Nutritional assessment using subjective global assessment identifies energy malnutrition and predicts mortality in patients with liver cirrhosis
by: Takao Miwa, et al.
Published: (2025-02-01)

Human placental extract improves liver cirrhosis in mice with regulation of macrophages and senescent cells
by: Natsuki Ishikawa, et al.
Published: (2025-03-01)

Recurrent Massive Hydrothorax in a Patient with Decompensated Liver Cirrhosis
by: K. S. Zemlyanukhina, et al.
Published: (2024-10-01)

Managing Liver Cirrhosis: a Multidisciplinary Approach
by: V. M. Durleshter, et al.
Published: (2020-09-01)